Addition of Baricitinib to COVID-19 Treatment Does Not Increase Bacterial Infection Compared to Standard Therapy: A Single-center Retrospective Study

Objective The coronavirus disease 2019 (COVID-19) pandemic continues to spread across the world, and the utility of many drugs for treatment has been suggested. However, few studies have examined the efficacy and safety of treatment with baricitinib, remdesivir, and dexamethasone. Methods A retrospe...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Internal Medicine 2022/08/01, Vol.61(15), pp.2273-2279
Hauptverfasser:	Kobe, Hiroshi, Ito, Akihiro, Nakanishi, Yosuke, Kuriyama, Akira, Tachibana, Hiromasa, Ishida, Tadashi
Format:	Artikel
Sprache:	eng
Schlagworte:	Bacteria Bacterial infections baricitinib Coronaviruses COVID-19 Dexamethasone Internal medicine Mortality Original Patients remdesivir
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!